EXOBIOSPHERE was founded in 2024 in Luxembourg with the vision of transforming the drug discovery process.  Recognizing the unique advantages of microgravity environments, EXOBIOSPHERE aims to provide a platform to unlock new insights into cellular behaviors that are not observable under Earth’s gravity.  By harnessing these insights, we strive to accelerate the development of novel therapeutics, ultimately improving human health both on Earth and in space.

EXOBIOSPHERE is poised to revolutionize the drug discovery process, providing our clients with the tools and insights necessary to develop new, effective therapies more rapidly and cost-effectively than ever before!